Literature DB >> 34243801

Gene-gene and gene-environment interactions on cord blood total IgE in Chinese Han children.

Li Hua1, Quanhua Liu1, Jing Li1, Xianbo Zuo2, Qian Chen3, Jingyang Li1, Yuwei Wang4, Haipei Liu1, Zhaobo Shen5, Yi Li5, Zenan Ma6, Shengdong Dong7, Ruoxu Ji1, Dingzhu Fang1, Yi Chen1, Wenwei Zhong1, Jun Zhang3, Jianhua Zhang8, Yixiao Bao9,10.   

Abstract

BACKGROUND: IL13, IL4, IL4RA, FCER1B and ADRB2 are susceptible genes of asthma and atopy. Our previous study has found gene-gene interactions on asthma between these genes in Chinese Han children. Whether the interactions begin in fetal stage, and whether these genes interact with prenatal environment to enhance cord blood IgE (CBIgE) levels and then cause subsequent allergic diseases have yet to be determined. This study aimed to determine whether there are gene-gene and gene-environment interactions on CBIgE elevation among the aforementioned five genes and prenatal environmental factors in Chinese Han population.
METHODS: 989 cord blood samples from a Chinese birth cohort were genotyped for nine single-nucleotide polymorphisms (SNPs) in the five genes, and measured for CBIgE levels. Prenatal environmental factors were collected using a questionnaire. Gene-gene and gene-environment interactions were analyzed with generalized multifactor dimensionality methods.
RESULTS: A four-way gene-gene interaction model (IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713) was regarded as the optimal one for CBIgE elevation (testing balanced accuracy = 0.5805, P = 9.03 × 10-4). Among the four SNPs, only IL13 rs20541 was identified to have an independent effect on elevated CBIgE (odds ratio (OR) = 1.36, P = 3.57 × 10-3), while the other three had small but synergistic effects. Carriers of IL13 rs20541 TT, IL13 rs1800925 CT/TT, IL4 rs2243250 TT and ADRB2 rs1042713 AA were estimated to be at more than fourfold higher risk for CBIgE elevation (OR = 4.14, P = 2.69 × 10-2). Gene-environment interaction on elevated CBIgE was found between IL4 rs2243250 and maternal atopy (OR = 1.41, P = 2.65 × 10-2).
CONCLUSIONS: Gene-gene interaction between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713, and gene-environment interaction between IL4 rs2243250 and maternal atopy begin in prenatal stage to augment IgE production in Chinese Han children.
© 2021. The Author(s).

Entities:  

Keywords:  Cord blood; Gene—environment interaction; Gene—gene interaction; IgE

Year:  2021        PMID: 34243801      PMCID: PMC8268446          DOI: 10.1186/s13223-021-00571-0

Source DB:  PubMed          Journal:  Allergy Asthma Clin Immunol        ISSN: 1710-1484            Impact factor:   3.406


Introduction

The worldwide prevalence of allergic diseases has dramatically increased during the past few decades, resulting in heavy burden to the whole society and huge medical expenditure around the world [1]. Allergic diseases have long been attributed to IgE-mediated inflammatory responses [2]. Evidence has demonstrated that regulation of IgE production may begin in utero, reflected in the levels of cord blood IgE (CBIgE) [3]. Elevated CBIgE has been shown to be a risk factor for the subsequent development of allergic diseases [4]. Recent studies have indicated that certain genes and environmental factors may interact to elevate CBIgE levels [5-7], with the heritability estimated around 84–95% [8]. Ober and Hoffjan reviewed 118 genes associated with asthma or atopy, among which 25 have been replicated in six or more independent samples and thus are considered to be true susceptibility genes [9]. The elite group of susceptible genes of asthma and atopy replicated in more than ten different studies include IL13, IL4, IL4RA, FCER1B and ADRB2, five important inflammatory genes associated with IgE levels [10-12]. Our previous study has found that gene–gene interactions on childhood asthma exist between these genes in Chinese Han population [13]. Whether the gene–gene interactions among the aforementioned five genes begin in fetal stage, and whether these genes interact with prenatal environment to enhance CBIgE production and then cause subsequent allergic diseases have yet to be determined. This study attempts to explore whether there are gene–gene and gene-environment interactions on CBIgE elevation among genetic variants in IL13, IL4, IL4RA, FCER1B and ADRB2 genes and prenatal environmental factors in Chinese Han population. This is the first study to investigate gene–gene and gene-environment interactions on CBIgE in the mainland of China. Elucidation of genetic and environmental determinants of CBIgE may allow for detection and prevention of allergic sensitization in early life.

Methods

Study participants

This study included 989 Chinese Han children from the Shanghai Allergy Cohort, which was a prospective birth cohort with infants recruited between 2012 and 2013 at two large tertiary hospitals in Shanghai, Xinhua Hospital and the International Peace Maternity & Child Health Hospital. Written informed consent was obtained from the mothers prior to delivery. Prenatal and perinatal epidemiologic and clinical information along with cord blood samples were collected by trained research nurses. The study was approved by the Ethics Committee of Xinhua Hospital and the International Peace Maternity & Child Health Hospital (approval number: XHEC-C-2012–003), and conducted according to the principles in the Declaration of Helsinki.

Epidemiologic and clinical information collection

Trained research nurses conducted face-to-face interviews using structured questionnaires, collecting information on maternal age, height, prepregnancy weight, education level, maternal atopy, prenatal pet exposure, prenatal active or secondhand smoking, and family income. Maternal atopy was referred to those mothers who had asthma, allergic rhinitis or atopic dermatitis along with detectable specific IgE. Prenatal pet exposure was defined as keeping cats or dogs at home during pregnancy. Information on parity, previous pregnancy, gestational age, date of birth, delivery mode, infants’ gender, birth weight and antenatal complications was obtained from medical records.

CBIgE measurement

CBIgE levels were determined by using ImmunoCAP Total IgE Low Range Assay [5] on the Phadia 250 (Thermo Scientific™, Waltham, Massachusetts, USA) according to the standard manufacturer’s protocols. Elevation of CBIgE levels was cut-off at ≥ 0.5 KU/L as previously described [5, 6].

Selection of genes and single nucleotide polymorphisms

This study focused on five candidate genes, including IL13, IL4, IL4RA, FCER1B and ADRB2, which are key inflammatory genes affecting IgE levels [10-12] and had been found associated with asthma or atopy by more than ten different studies [9]. Our previous study had identified gene–gene interactions on asthma between these genes in Chinese Han children [13]. Within these genes, nine known functional single-nucleotide polymorphisms (SNPs) [13] with minor allele frequency greater than 10% were chosen for analysis, as shown in Table 1.
Table 1

Candidate genes and SNPs analyzed in this study

GeneSNPrs NumberChromosome positionLocation
IL13− 1112C > Trs18009255:132,657,117Promoter
IL13 + 1923C > Trs12956865:132,660,151Intron 3
IL13R110Qrs205415:132,660,272Exon 4
IL4− 590C > Trs22432505:132,673,462Promoter
ADRB2R16Grs10427135:148,826,877Exon1
FCER1B− 109C > Trs144158611:60,088,555Promoter
FCER1BE237Grs56910811:60,095,631Exon7
IL4RAI75Vrs180501016:27,344,882Exon 5
IL4RAQ551Rrs180127516:27,363,079Exon 12

SNP single-nucleotide polymorphism, rs reference SNP

Candidate genes and SNPs analyzed in this study SNP single-nucleotide polymorphism, rs reference SNP

Genotyping

Genomic DNA was extracted from cord blood using QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany). Genotyping of the nine SNPs was performed by matrix-assisted laser desorption / ionization time of flight mass spectrometry (MALDI-TOF MS) [14] using the MassARRAY iPLEX platform (Sequenom Inc, San Diego, CA, USA) according to the manufacturer’s instructions. Laboratory personnel were blinded to CBIgE status. The overall call rate was 98.6%. Genotyping quality control included 5% duplicate and negative samples. Genotyping concordance rate was higher than 98%.

Statistical analysis

Associations between CBIgE elevation and the epidemiologic characteristics of the study subjects were assessed by the χ2 test. The Hardy–Weinberg equilibrium test for each of the nine SNPs was performed in the total population with the χ2 statistics. Association of elevated CBIgE in subjects with each SNP was analyzed by using the Pearson’s χ2 test. In addition to the allelic test of association, dominant and recessive genetic models were tested for the nine SNPs by logistic regression analysis. P value, odds ratio (OR) and 95% confidence interval (95% CI) were calculated by using the PLINK program (http://pngu.mgh.harvard.edu/~purcell/plink/). A two-tailed P value ≤ 0.0055 after Bonferroni Multiple Testing correction was considered statistically significant. Gene–gene interactions were analyzed with GMDR (Version 1.0), which is a free, open-source interaction analysis tool, aimed to perform gene–gene interaction with generalized multifactor dimensionality reduction (GMDR) methods [15]. The model that maximizes the testing balanced accuracy (TBA) and minimizes the statistical significance is selected. TBA indicates the accuracy of classification of cases and controls. Heuristically, a satisfactory TBA is higher than 0.55. Gene–gene interactions revealed by GMDR analyses were validated by χ2 tests. Gene-environment interactions were evaluated by logistic regression analysis and GMDR approach. Linkage disequilibrium (LD) was calculated for the SNPs located on one chromosome. The detection power of the sample size in this study was 0.88 based on the minor allele frequency of 0.25 and its OR for CBIgE elevation at 1.30.

Results

Association between CBIgE elevation and the epidemiologic characteristics of the study subjects

There were 989 Chinese Han infants in this study, of whom 27.1% had elevated CBIgE levels. Table 2 presents the distribution of CBIgE concentrations by epidemiologic characteristics of the study subjects. Cesarean section and male gender were associated with elevated CBIgE levels (P < 0.05).
Table 2

Associations between CBIgE elevation and the epidemiologic characteristics of the study subjects

PhenotypesN (%)Elevated rate of CBIgEP value*
Maternal age (y)
  < 2562 (6.4)17 (27.4)6.92 × 10–1
 25–29500 (51.9)128 (25.6)
 30–34325 (33.7)92 (28.3)
  ≥ 3577 (8.0)24 (31.2)
Maternal prepregnancy BMI (kg/m2)
  < 18.5150 (15.6)42 (28.0)5.79 × 10–1
 18.5–24.9694 (72.1)182 (26.2)
 25–29.992 (9.6)29 (31.5)
  ≥ 3026 (2.7)9 (34.6)
Maternal education
 Middle school or lower28 (2.9)6 (21.4)5.48 × 10–1
 High school112 (11.6)27 (24.1)
 College or higher825 (85.5)230 (27.9)
Family income (CNY)
  < 100 K273 (27.6)74 (27.1)9.98 × 10–1
  ≥ 100 K540 (54.6)146 (27.0)
 Unknown176 (17.8)48 (27.3)
Maternal atopya
 No824 (86.5)219 (26.6)2.17 × 10–1
 Yes129 (13.5)41 (31.8)
Prenatal pet exposureb
 No857 (89.1)234 (27.3)8.90 × 10–1
 Yes105 (10.9)28 (26.7)
Prenatal active or secondhand smoking
 No577 (59.9)158 (27.4)9.32 × 10–1
 Yes387 (40.1)105 (27.1)
Parity
 None868 (89.9)235(27.1)9.20 × 10–1
  ≥ 198 (10.1)27 (27.6)
Previous pregnancy
 None629 (65.1)169 (26.9)8.08 × 10–1
  ≥ 1337 (34.9)93 (27.6)
Gestational age (wk)
  < 3733 (3.4)7 (21.2)
 37–39686 (71.0)196 (28.6)2.70 × 10–1
  ≥ 40247 (25.6)59 (23.9)
Season of birth
 Summer (Jun.—Aug.)170 (17.7)46 (27.1)4.90 × 10–1
 Autumn (Sep.—Nov.)451 (47.1)131 (29.0)
 Winter (Dec.—Feb.)337 (35.2)85 (25.2)
Delivery mode
 Vaginal229 (23.7)50 (21.8)3.93 × 10–2
 Cesarean section737 (76.3)212 (28.8)
Gender
 Boy499 (51.7)156 (31.3)2.28 × 10–3
 Girl466 (48.3)105 (22.5)
Birth weight (g)
  < 250024 (2.5)8 (33.3)7.86 × 10–1
 2500–4000857 (88.7)231 (27.0)
  ≥ 400085 (8.8)23 (27.1)
Antenatal complicationsc
 No763 (81.2)206 (27.0)6.26 × 10–1
 Yes177 (18.8)51 (28.8)

The missing data: maternal age (n = 25); maternal prepregnancy BMI (n = 27); maternal education (n = 24); maternal atopy (n = 36); prenatal pet exposure (n = 27); prenatal active or secondhand smoking (n = 25); parity (n = 23); previous pregnancy (n = 23); gestational age (n = 23); season of birth (n = 31); delivery mode (n = 23); gender (n = 24); birth weight (n = 23); antenatal complications (n = 49). The missing data were not from the same individuals for each variable

CBIgE cord blood IgE

aMaternal atopy was referred to those mothers who had asthma, allergic rhinitis or atopic dermatitis along with detectable specific IgE

bKeeping cats or dogs at home during pregnancy

cPregnancy hypertension, diabetes, infection or intrauterine growth retardation

*χ2 test was used to analyze associations between CBIgE elevation and the epidemiologic characteristics

Associations between CBIgE elevation and the epidemiologic characteristics of the study subjects The missing data: maternal age (n = 25); maternal prepregnancy BMI (n = 27); maternal education (n = 24); maternal atopy (n = 36); prenatal pet exposure (n = 27); prenatal active or secondhand smoking (n = 25); parity (n = 23); previous pregnancy (n = 23); gestational age (n = 23); season of birth (n = 31); delivery mode (n = 23); gender (n = 24); birth weight (n = 23); antenatal complications (n = 49). The missing data were not from the same individuals for each variable CBIgE cord blood IgE aMaternal atopy was referred to those mothers who had asthma, allergic rhinitis or atopic dermatitis along with detectable specific IgE bKeeping cats or dogs at home during pregnancy cPregnancy hypertension, diabetes, infection or intrauterine growth retardation *χ2 test was used to analyze associations between CBIgE elevation and the epidemiologic characteristics

Association between CBIgE elevation and single SNPs

All the nine SNPs were in Hardy–Weinberg equilibrium (P > 0.05). As shown in Table 3, SNPs IL13 rs1295686 and IL13 rs20541 were solely associated with CBIgE elevation. The A allele of rs1295686 (OR = 1.37, P = 2.73 × 10–3) and T allele of rs20541 (OR = 1.36, P = 3.57 × 10–3) were significantly increased in elevated CBIgE group compared with normal group. The most significant association with CBIgE elevation was found under recessive model for the two SNPs. Significant association with CBIgE elevation was not found among the other seven loci (P > 0.0055, after Bonferroni Multiple Testing correction).
Table 3

Genetic effects of single SNPs on CBIgE elevation

SNPCBIgE levelsRisk alleleRisk allele frequency, n (%)P value *OR(95%CI)Genotype frequency AA/AB/BB n (%)DominantP valueOR(95%CI)RecessiveP valueOR(95%CI)
IL13CC/CT/TT
rs1800925ElevatedT102 (19.2)5.17 × 10–2170(63.9)/90(33.8)/6(2.3)2.79 × 10–29.77 × 10–1
Normal223 (15.5)1.29 (1.00–1.67)512(71.2)/191(26.6)/16(2.2)1.40 (1.04–1.88)1.01 (0.39–2.62)
IL13GG/GA/AA
rs1295686ElevatedA204 (38.5)2.73 × 10–397(36.6)/132(49.8)/36(13.6)8.71 × 10–32.18 × 10–2
Normal451 (31.3)1.37 (1.12–1.69)331(46.0)/327(45.4)/62(8.6)1.47 (1.10–1.97)1.67 (1.08–2.58)
IL13CC/CT/TT
rs20541ElevatedT203 (38. 5)3.57 × 10–397(36.7)/131(49.6)/36(13.6)1.23 × 10–22.07 × 10–2
Normal453 (31.5)1.36 (1.11–1.68)329(45.7)/329(45.7)/62(8.6)1.45 (1.08–1.94)1.68 (1.08–2.60)
IL4TT/TC/CC
rs2243250ElevatedC109 (20.6)7.55 × 10–1168(63.4)/85(32.1)/12(4.5)7.00 × 10–19.71 × 10–1
Normal287 (19.9)1.04 (0.81–1.33)466(64.7)/221(30.7)/33(4.6)1.06 (0.79–1.42)0.99 (0.50–1.94)
ADRB2AA/AG/GG
rs1042713ElevatedA296 (61. 7)1.41 × 10–197(40.4)/102(42.5)/41(17.1)8.81 × 10–25.94 × 10–1
Normal763 (57.8)1.17 (0.95–1.46)226(34.2)/311(47.1)/123(18.6)0.77 (0.57–1.04)0.90 (0.61–1.33)
FCER1BTT/TC/CC
rs1441586ElevatedC187 (35.4)3.41 × 10–1108(40.9)/125(47.3)/31(11.7)3.82 × 10–15.10 × 10–1
Normal477 (33.1)1.11 (0.90–1.37)317(44.0)/329(45.7)/74(10.3)1.14 (0.85–1.51)1.16 (0.74–1.81)
FCER1BTT/TC/CC
rs569108ElevatedC91 (17.0)7.26 × 10–1184(68.7)/77(28.7)/7(2.6)7.47 × 10–18.20 × 10–1
Normal235 (16.3)1.05 (0.80–1.37)502(69.7)/201(27.9)/17(2.4)1.05 (0.78–1.42)1.11 (0.45–2.71)
IL4RAGG/GA/AA
rs1805010ElevatedG274 (51. 9)3.22 × 10–172(27.3)/130(49.2)/62(23.5)3.84 × 10–14.59 × 10–1
Normal708 (49.4)1.11 (0.91–1.35)176(24.5)/356(49.7)/185(25.8)0.87 (0.63–1.19)0.88 (0.63–1.23)
IL4RAAA/AG/GG
rs1801275ElevatedA442 (83.4)6.66 × 10–1178(67.2)/86(32.5)/1 (0.4)6.97 × 10–13.09 × 10–2
Normal1189 (82.6)1.06 (0.81–1.38)493(68.5)/203(28.2)/24(3.3)1.06 (0.79–1.43)0.11 (0.01–0.82)

SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval

*P Values for Pearson’s χ2 tests

†Dominant model (AA vs AB + BB) and recessive model (AA + AB vs BB), where A is the major allele and B is the minor allele

‡P Values for logistic analyses

Genetic effects of single SNPs on CBIgE elevation SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval *P Values for Pearson’s χ2 tests †Dominant model (AA vs AB + BB) and recessive model (AA + AB vs BB), where A is the major allele and B is the minor allele ‡P Values for logistic analyses

Gene–gene interactions on CBIgE elevation

Gene–gene interactions on CBIgE elevation were explored among all the nine SNPs by GMDR approach. Totally, there were four models exhibiting a TBA higher than 0.55, as shown in Table 4. Based on the TBA and P values, significant multi-loci interactions were found in the four models (P < 0.05). Among them, the four-way interaction model (IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713) which showed the highest TBA and lowest P value (TBA = 0.5805, P = 9.03 × 10–4), was regarded as the optimal one. As the four SNPs that made up the optimal model are located on one chromosome, pairwise LD of them was calculated (r2 < 0.3), indicating a low LD between them. Interactions between the four SNPs of the optimal model were further validated by χ2 tests. Table 5 shows that individuals carrying IL13 rs20541 TT, IL13 rs1800925 CT/TT, IL4 rs2243250 TT and ADRB2 rs1042713 AA had a significantly higher risk of CBIgE elevation compared with those without any of the four risk genotypes (OR = 4.14, P = 2.69 × 10–2), and also greater than those with less than four risk genotypes.
Table 4

Summary of gene–gene interactions for CBIgE elevation by GMDR analysis

Interacting SNPsTBAP value
IL13 rs20541 × ADRB2 rs10427130.56211.07 × 10–2
IL13 rs1800925 × IL4 rs2243250 × ADRB2 rs10427130.55917.77 × 10–3
IL13 rs20541 × IL13 rs1800925 × IL4 rs2243250 × ADRB2 rs10427130.58059.03 × 10–4
IL13 rs20541 × IL13 rs1800925 × IL13 rs1295686 × IL4 rs2243250 × ADRB2 rs10427130.57241.53 × 10–3

CBIgE cord blood IgE, GMDR generalized multifactor dimensionality reduction, SNP single-nucleotide polymorphism, TBA Testing balanced accuracy

Table 5

Interactions between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713 genotypes for CBIgE elevation

Number of risk genotype for the four SNPs aCBIgE levelsP value OR (95%CI)
Elevated, n (%)Normal, n (%)
031 (13.2)110 (16.8)1
192 (39.1)265 (40.4)3.78 × 10–11.23 (0.78–1.96)
271 (30.2)217 (33.1)5.42 × 10−11.16 (0.72–1.88)
334 (14.5)58 (8.8)1.28 × 10–22.08 (1.16–3.72)
47 (3.0)6 (0.9)2.69 × 10–24.14 (1.30–13.22)

CBIgE cord blood IgE, SNP single-nucleotide polymorphism, OR odds ratio, CI confidence interval

aRisk genotypes were TT, CT/TT, TT, and AA for rs20541, rs1800925, rs2243250, and rs1042713, respectively

†P Values for χ2 tests

Summary of gene–gene interactions for CBIgE elevation by GMDR analysis CBIgE cord blood IgE, GMDR generalized multifactor dimensionality reduction, SNP single-nucleotide polymorphism, TBA Testing balanced accuracy Interactions between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713 genotypes for CBIgE elevation CBIgE cord blood IgE, SNP single-nucleotide polymorphism, OR odds ratio, CI confidence interval aRisk genotypes were TT, CT/TT, TT, and AA for rs20541, rs1800925, rs2243250, and rs1042713, respectively †P Values for χ2 tests

Gene-environment interactions on CBIgE elevation

Logistic regression analysis and GMDR approach were applied to search the potential gene-environment interactions on CBIgE elevation between the nine SNPs and environmental factors including prenatal pet exposure, prenatal active or secondhand smoking, maternal atopy, maternal age, maternal prepregnancy BMI, delivery mode, infants’ gender and season of birth. By using logistic regression analysis, it was found that C allele of IL4 rs2243250 interacted with maternal atopy to elevate CBIgE levels (OR = 1.41, P = 2.65 × 10–2), as shown in Table 6. However, no significant gene-environment interaction was found by GMDR analysis.
Table 6

Interactions between the nine SNPs and maternal atopy for CBIgE elevation

GeneSNPMinor alleleOR(95%CI)P value*
IL13rs1800925T1.21 (0.86–1.71)2.81 × 10–1
IL13rs1295686A0.89 (0.67–1.20)4.53 × 10–1
IL13rs20541T0.91 (0.68–1.22)5.25 × 10–1
IL4rs2243250C1.41 (1.04–1.91)2.65 × 10–2
ADRB2rs1042713G0.86 (0.66–1.14)2.94 × 10–1
FCER1Brs1441586C1.21 (0.91–1.59)1.91 × 10–1
FCER1Brs569108C1.19 (0.84–1.69)3.19 × 10–1
IL4RArs1805010A0.89 (0.68–1.16)3.77 × 10–1
IL4RArs1801275G1.23 (0.88–1.72)2.31 × 10–1

SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval

*P Values were tested by multivariate logistic regression, adjusted for other genes, but not for other environmental factors

Interactions between the nine SNPs and maternal atopy for CBIgE elevation SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval *P Values were tested by multivariate logistic regression, adjusted for other genes, but not for other environmental factors

Discussion

IgE-mediated reaction is the central component of allergic diseases. Five key inflammatory genes affecting IgE levels, including IL13, IL4, IL4RA, FCER1B and ADRB2 [10-12], have been demonstrated associated with asthma or atopy by more than ten different studies [9]. Our previous study has found that gene–gene interactions on asthma exist between these genes in Chinese Han children [13]. This study attempted to determine whether the interactions begin in utero, and whether these genes interact with prenatal environmental factors to increase CBIgE levels and induce subsequent allergic diseases. Of the models tested using GMDR approach, the four-way gene–gene interaction model consisting of IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713 was chosen as the optimal one for CBIgE elevation based on its TBA and P value. Among the four SNPs, only IL13 rs20541 was identified to have an independent effect on CBIgE elevation, while the other three had small but synergistic effects. Carriers of IL13 rs20541 TT, IL13 rs1800925 CT/TT, IL4 rs2243250 TT and ADRB2 rs1042713 AA were estimated to be at more than fourfold higher risk for CBIgE elevation. Among these genes and prenatal environmental factors, only IL4 rs2243250 and maternal atopy were found to have interactions on elevated CBIgE. This is the first study to elucidate genetic and environmental determinants of CBIgE in Han population of mainland China. To our knowledge, this study is also the first to identify gene–gene interactions between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713 on CBIgE elevation. IL13 and IL4 genes encode cytokines interleukin 13 (IL13) and IL4, which share a common signaling pathway in binding to their receptors on human B cells, and switch immunoglobulin production from IgM to IgE [16]. ADRB2 gene encodes Beta2-adrenergic receptor (ADRB2). Stimulation of ADRB2 on B cells responding to allergen enhances IgE production via a unique signaling pathway, independently of class switch recombination [17, 18]. IL13, IL4 and ADRB2 are all associated with IgE levels. IL13 rs20541 TT genotype, IL13 rs1800925 T allele, IL4 rs2243250 TT genotype and ADRB2 rs1042713 AA genotype have been associated with increased IL13 concentration [19], enhanced IL13 promoter activity [20], augmented IL4 levels [21], and decreased downregulation of ADRB2 [22], respectively. How these four varients interact with each other biologically to promote IgE production in prenatal stage need further functional studies in vitro and in vivo. In this study, gene-environment interaction on elevated CBIgE was found between IL4 rs2243250 and maternal atopy. Maternal atopy has been reported to modify cord blood immune response and it may provide an intrauterine environment that influences fetal immune development and results in allergic predisposition [23-25]. IL4 gene polymorphism affects cytokine IL4 levels [26]. How maternal atopy interacts with IL4 gene variants to enhance antenatal IgE production need future biological studies. Our study confirmed the independent role of IL13 rs20541 and rs1295686 on CBIgE elevation, and also found the association of cesarean section and male gender with elevated CBIgE levels, consistent with previous reports [3, 5–7, 27]. However, no interactions were identified among them. To date, only a few studies have explored gene–gene and gene-environment interactions on CBIgE elevation. One study in a predominantly black sample reported that three IL13 SNPs (rs1295686, rs1800925 and rs206974) could jointly influence CBIgE concentration [3]. One study in a birth cohort in Korea identified interactions between reactive oxygen species genes, prenatal exposure to home renovation and maternal atopy on CBIgE response [28]. Another study, in a Chinese population in Taiwan, found that IL13 rs20541, male sex and prenatal environmental tobacco smoke interacted on antenatal IgE production [5]. In this study, we found a four-way genetic interactions among IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713, and a two-way gene-environment interactions between IL4 rs2243250 and maternal atopy on CBIgE elevation. The variation of the gene–gene and gene-environment interactions on fetal IgE production may be in part explained by different populations and different genetic and environmental factors focused in different studies. Therefore, when we move forward to identify constellations of interacting genes and environments that influence antenatal IgE production, replication studies in different populations are required. There are some limitations in this study. First, only five genes (IL13, IL4, IL4RA, FCER1B and ADRB2) were chosen as candidate genes. However, these five genes are susceptible genes of asthma and atopy replicated in more than ten different studies [9], and our previous study has found that gene–gene interactions on asthma exist between these genes in Chinese Han children [13]. Second, the subjects’ environmental exposures were evaluated using a self-reported questionnaire, which might lead to an underestimation of the associations of certain environmental exposures. Genes and environmental factors interact to elevate CBIgE concentrations [5-7], with the heritability estimated around 84–95% [8]. In our future studies, more candidate genes especially those from genome-wide association studies should be included and direct measurement of certain environmental exposures is needed. Third, cord blood IgA concentrations were not measured to exclude subjects whose circulation was contaminated by maternal blood. However, previous studies using cord blood IgA levels as an indicator of maternal contamination have reported a very low rate of contamination [29]. Therefore CBIgE is unlikely to be contaminated by maternal IgE [3]. In summary, Gene–gene interaction between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713, and gene-environment interaction between IL4 rs2243250 and maternal atopy begin in fetal stage to increase IgE production in Chinese Han children. After future functional and replication studies, these findings may be translated into specific strategies for early prediction and prevention of allergy.
  29 in total

1.  A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population.

Authors:  N Hizawa; E Yamaguchi; E Jinushi; Y Kawakami
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

2.  Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity.

Authors:  Byung Soo Kim; Se-Min Park; Tae Gi Uhm; Jin Hyun Kang; Jong-Sook Park; An-Soo Jang; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Cheon-Soo Hong; Yong Won Lee; Jae-Young Lee; Byoung Whui Choi; Hae-Sim Park; Byung Lae Park; Hyoung Doo Shin; Il Yup Chung; Choon-Sik Park
Journal:  Pharmacogenet Genomics       Date:  2010-12       Impact factor: 2.089

Review 3.  Asthma genetics 2006: the long and winding road to gene discovery.

Authors:  C Ober; S Hoffjan
Journal:  Genes Immun       Date:  2006-03       Impact factor: 2.676

4.  The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner.

Authors:  Georg Pongratz; Jaclyn W McAlees; Daniel H Conrad; Robert S Erbe; Karen M Haas; Virginia M Sanders
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  A role of FCER1A and FCER2 polymorphisms in IgE regulation.

Authors:  V Sharma; S Michel; V Gaertner; A Franke; C Vogelberg; A von Berg; A Bufe; A Heinzmann; O Laub; E Rietschel; B Simma; T Frischer; J Genuneit; D P Potaczek; M Kabesch
Journal:  Allergy       Date:  2013-12-20       Impact factor: 13.146

6.  Beta2-ADR haplotypes/polymorphisms associate with bronchodilator response and total IgE in grass allergy.

Authors:  G Woszczek; M Borowiec; A Ptasinska; S Kosinski; R Pawliczak; M L Kowalski
Journal:  Allergy       Date:  2005-11       Impact factor: 13.146

7.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

Authors:  S A Green; J Turki; P Bejarano; I P Hall; S B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

8.  Gene-gene and gene-environment interactions on IgE production in prenatal stage.

Authors:  K D Yang; J-C Chang; H Chuang; H-M Liang; H-C Kuo; Y-S Lee; T-Y Hsu; C-Y Ou
Journal:  Allergy       Date:  2009-11-25       Impact factor: 13.146

9.  Cytokine gene polymorphisms in Tunisian endemic pemphigus foliaceus: a possible role of il-4 variants.

Authors:  Amina Toumi; O Abida; M Ben Ayed; A Masmoudi; H Turki; H Masmoudi
Journal:  Hum Immunol       Date:  2013-01-29       Impact factor: 2.850

10.  Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma.

Authors:  Kazuhiko Arima; Ritsuko Umeshita-Suyama; Yasuhisa Sakata; Mina Akaiwa; Xiao-Quan Mao; Tadao Enomoto; Yoshio Dake; Shin-ichiro Shimazu; Tetsuji Yamashita; Naoto Sugawara; Scott Brodeur; Raif Geha; Raj K Puri; Mohamad H Sayegh; Chaker N Adra; Naotaka Hamasaki; Julian M Hopkin; Taro Shirakawa; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2002-06       Impact factor: 10.793

View more
  1 in total

Review 1.  Gene-environment interactions in childhood asthma revisited; expanding the interaction concept.

Authors:  Natalia Hernandez-Pacheco; Maura Kere; Erik Melén
Journal:  Pediatr Allergy Immunol       Date:  2022-05       Impact factor: 5.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.